Latest S-1 registration statements

Leef Brands, Inc. announced an 18% revenue increase and a 63% reduction in net loss for the nine months ended September 30, 2025, driven by vertical integration and New York market entry.

Grayscale Avalanche Trust (AVAX) filed an S-1/A amendment, detailing its structure as a passive investment vehicle aiming to track AVAX value, with plans for NASDAQ listing under GAVX and potential staking functionality.

Greenland Technologies Holding Corporation announces a public offering of 6 million units, each comprising one ordinary share and four-fifths of a warrant, to raise approximately $5.75 million for working capital and general corporate purposes.

FibroBiologics, a clinical-stage biotech, filed an S-1 registration statement for the resale of up to 22.5 million common shares underlying warrants issued in recent private placements, with potential gross proceeds of $7.5 million to the company upon warrant exercise.

Capstone Green Energy Holdings, Inc. filed an S-1 registration statement for the resale of up to 7,500,000 shares of common stock by existing selling stockholders, following a recent $15 million private placement.

Terrestrial Energy Inc. has finalized its business combination with HCM II Acquisition Corp., raising over $292 million to accelerate the commercialization of its Integral Molten Salt Reactor (IMSR) technology.

BriaCell Therapeutics Corp. files an S-1 registration statement for a best-efforts public offering of up to $25 million in common and pre-funded units to fund working capital and advance business objectives.

Rubber Leaf Inc. reported a significant increase in net losses and negative working capital for 2024, alongside operational delays and ongoing litigation, as it seeks to raise $22 million in a public offering.

SRx Health Solutions, Inc. is undergoing a significant business transformation, divesting its Canadian healthcare operations to focus on its Halo pet wellness brand and a proposed acquisition in AI and crypto technology, while facing substantial financial challenges and potential dilution.

Verde Resources, a sustainable road construction materials company, files an S-1 registration statement for a public offering and Nasdaq listing, highlighting its BioAsphalt technology and exclusive licensing agreement with Ergon.

Beneficient has filed an S-1 registration statement for the resale of up to 71,017,840 Class A common stock shares by selling holders, while grappling with significant net losses, going concern doubts, and ongoing legal and regulatory issues.

Biotricity Inc. files S-1, detailing expansion in cardiac monitoring solutions and AI development, alongside significant financial challenges including recurring losses and going concern doubt.

Farlong Holding Corporation filed an S-1/A amendment for its initial public offering, seeking to raise $14.5 million while disclosing recurring losses and substantial doubt about its ability to continue as a going concern.

BitGo Holdings, a leading digital asset infrastructure company, filed its S-1/A for an initial public offering, showcasing significant revenue growth and increased assets on platform, despite past market volatility.

Oncotelic Therapeutics, a clinical-stage biopharmaceutical company, filed an S-1/A registration statement for the resale of 115.6 million common shares by Mast Hill Fund, LP, while continuing to face substantial doubt about its ability to continue as a going concern.

Cycurion, Inc. filed an S-1 registration statement for the resale of nearly 5 million common shares by a selling stockholder and outlined a recent $6 million private placement, while reporting significant Q3 2025 net losses and ongoing going concern doubts.

Jade Biosciences filed a Form S-1 to register 3.21 million shares for resale from its December 2025 $45 million PIPE, with no proceeds to the company.

Splash Beverage Group, Inc. filed an S-1 registration statement for the resale of up to 7.76 million common shares by selling stockholders, highlighting severe liquidity issues, recurring losses, and a critical need for capital to resume operations and pursue new ventures.

Graphjet Technology, a graphene and graphite producer, is appealing a Nasdaq delisting while reporting significant net losses and negative working capital, despite patented biomass conversion technology.

CH4 Natural Solutions Corporation files for a $300M IPO, offering units of Class A shares and warrants, but faces significant dilution and a management team with a mixed SPAC track record including multiple failures and ongoing litigation.

Estrella Immunopharma, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of up to 2,541,206 shares of common stock by selling stockholders, while reporting continued operating losses and a going concern doubt.

cbdMD, Inc. filed an S-1/A to register 1.7 million common shares for resale by Series B Preferred Stock holders, while detailing recent capital raises, reduced operating losses, and significant regulatory challenges.

BNB Plus Corp. files an S-1/A to register 18.7 million shares for resale by selling stockholders, detailing its new BNB-focused digital asset treasury strategy and ongoing LineaRx biopharmaceutical business.

American Battery Materials Inc. filed an S-1/A registration statement for a public offering of 1,550,388 shares to fund its Lisbon Valley lithium and magnesium extraction project in Utah.

Onconetix, Inc. is registering nearly 30 million shares for resale by institutional investors, while simultaneously facing substantial doubt about its ability to continue as a going concern and abandoning its ENTADFI product.

Movano Inc. is undergoing a reverse merger with AI cloud computing company Corvex Inc., simultaneously establishing a $1 billion committed equity facility with Chardan Capital Markets LLC and addressing Nasdaq listing compliance issues.

Fusemachines Inc. has filed an S-1 registration statement for the issuance and resale of common stock and warrants following its business combination, while auditors express substantial doubt about its ability to continue as a going concern.

Momentus Inc. files S-1 to register 1.2 million shares for resale by existing stockholders amidst significant financial challenges and ongoing Nasdaq compliance concerns.

Odyssey Health files S-1 for the resale of 18 million common shares by Mast Hill Fund, L.P., with potential for up to $25 million in future funding.

iSpecimen Inc. filed an S-1/A to register 1,559,828 shares for resale by selling stockholders, while also detailing its new $200 million Solana blockchain-based corporate treasury reserve initiative and ongoing Nasdaq compliance challenges.